CIA
Capital Impact Advisors Portfolio holdings
AUM
$332M
This Quarter Return
+10.7%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$286M
AUM Growth
+$286M
(-30%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-42.08%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
143
New
41
Increased
10
Reduced
49
Closed
34
Top Buys
| 1 |
Omnicom Group
OMC
|
$8.82M |
| 2 |
Service Corp International
SCI
|
$8.06M |
| 3 |
Stifel
SF
|
$7M |
| 4 |
Advance Auto Parts
AAP
|
$6.94M |
| 5 |
Colliers International
CIGI
|
$6.17M |
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
$17.3M |
| 2 |
Twist Bioscience
TWST
|
$8.68M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$8.27M |
| 4 |
Exact Sciences
EXAS
|
$7.93M |
| 5 |
Veracyte
VCYT
|
$7.89M |
Sector Composition
| 1 | Healthcare | 25.23% |
| 2 | Technology | 20.11% |
| 3 | Consumer Discretionary | 16.12% |
| 4 | Financials | 12.25% |
| 5 | Communication Services | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Editas Medicine
EDIT
$231M
| $377K | 0.13% |
8,965
-121,035
| -93% | -$5.09M |
|
|
102
Intellia Therapeutics
NTLA
$1.22B
| $359K | 0.13% |
4,468
-215,532
| -98% | -$17.3M |
|
103
SS&C Technologies
SSNC
$21.7B
| $303K | 0.11% |
+4,341
| New | +$303K |
|
104
MongoDB
MDB
$25.7B
| $200K | 0.07% |
+749
| New | +$200K |
|
105
Impinj
PI
$5.45B
| $188K | 0.07% |
3,301
-47,015
| -93% | -$2.68M |
|
106
Ultragenyx Pharmaceutical
RARE
$2.89B
| $179K | 0.06% |
1,572
-24,010
| -94% | -$2.73M |
|
107
Phreesia
PHR
$1.88B
| $141K | 0.05% |
2,703
-41,297
| -94% | -$2.15M |
|
108
Castle Biosciences
CSTL
$696M
| $139K | 0.05% |
2,031
-22,969
| -92% | -$1.57M |
|
109
Mistras Group
MG
$302M
| $65K | 0.02% |
+5,719
| New | +$65K |
|
110
Allogene Therapeutics
ALLO
$251M
| – | – |
-41,800
| Closed | -$1.06M |
|
111
Arcturus Therapeutics
ARCT
$462M
| – | – |
-155,000
| Closed | -$6.72M |
|
112
Arrowhead Research
ARWR
$3.05B
| – | – |
-88,183
| Closed | -$6.77M |
|
113
Beam Therapeutics
BEAM
$1.66B
| – | – |
-25,000
| Closed | -$2.04M |
|
114
Datadog
DDOG
$47.7B
| – | – |
-44,000
| Closed | -$4.33M |
|
|
DOYU
115
DouYu International Holdings
DOYU
$233M
| – | – |
-150,000
| Closed | -$1.66M |
|
116
Fate Therapeutics
FATE
$120M
| – | – |
-32,000
| Closed | -$2.91M |
|
117
Fastly
FSLY
$1.12B
| – | – |
-50,000
| Closed | -$4.37M |
|
118
GeoPark
GPRK
$340M
| – | – |
-13,042
| Closed | -$4.68M |
|
119
Ionis Pharmaceuticals
IONS
$6.79B
| – | – |
-63,707
| Closed | -$3.6M |
|
120
Kura Oncology
KURA
$686M
| – | – |
-62,331
| Closed | -$2.04M |
|
121
Li Auto
LI
$23.7B
| – | – |
-40,000
| Closed | -$1.15M |
|
122
Netflix
NFLX
$513B
| – | – |
-10,386
| Closed | -$5.62M |
|
123
Natera
NTRA
$23.1B
| – | – |
-50,000
| Closed | -$4.98M |
|
124
Okta
OKTA
$16.4B
| – | – |
-15,000
| Closed | -$3.81M |
|
125
Pacific Biosciences
PACB
$393M
| – | – |
-300,000
| Closed | -$7.78M |
|